Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative gemcitabine-based adjuvant chemotherapy after radical resection of biliary tract cancer
ChiCTR-TRC-09000477Phase 4Completed
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Aug 2009
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gemcitabine, fluorouracil and oxaliplatin in biliary cancer (3 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoint: Overall survival rate. Started Aug 2009; status: completed.
02
Drugs
gemcitabinefluorouraciloxaliplatin
03
Conditions
biliary cancer
Beyond the preview
Go deeper on ChiCTR-TRC-09000477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000477.